BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

16 related articles for article (PubMed ID: 10684520)

  • 1. Differences in circadian variation in QT interval of the ECG in women compared to men.
    Rabkin SW; Singh I
    Am J Cardiovasc Dis; 2023; 13(6):363-371. PubMed ID: 38205066
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of drug-induced QT interval prolongation: implications for drug approval and labelling.
    Malik M; Camm AJ
    Drug Saf; 2001; 24(5):323-51. PubMed ID: 11419561
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rate dependence of sotalol-induced prolongation of ventricular repolarization during exercise in humans.
    Funck-Brentano C; Kibleur Y; Le Coz F; Poirier JM; Mallet A; Jaillon P
    Circulation; 1991 Feb; 83(2):536-45. PubMed ID: 1846784
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of amiodarone, sematilide, and sotalol on QT dispersion.
    Cui G; Sen L; Sager P; Uppal P; Singh BN
    Am J Cardiol; 1994 Nov; 74(9):896-900. PubMed ID: 7526675
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diurnal pattern of QTc interval: how long is prolonged? Possible relation to circadian triggers of cardiovascular events.
    Molnar J; Zhang F; Weiss J; Ehlert FA; Rosenthal JE
    J Am Coll Cardiol; 1996 Jan; 27(1):76-83. PubMed ID: 8522713
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quantification of ventricular repolarization heterogeneity during moxifloxacin or sotalol administration using [Formula: see text]-index.
    Rivolta MW; Mainardi LT; Sassi R
    Physiol Meas; 2015 Apr; 36(4):803-11. PubMed ID: 25798997
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diurnal QT analysis in patients with sotalol after cardioversion of atrial fibrillation.
    Lenhoff H; Darpö B; Page A; Couderc JP; Tornvall P; Frick M
    Ann Noninvasive Electrocardiol; 2021 Jul; 26(4):e12834. PubMed ID: 33629473
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of Sotalol on the Circadian Rhythmicity of Heart Rate and QT Intervals With a Noninvasive Index of Reverse-Use Dependency.
    Sharma PP; Sarma JS; Singh BN
    J Cardiovasc Pharmacol Ther; 1999 Jan; 4(1):15-21. PubMed ID: 10684520
    [TBL] [Abstract][Full Text] [Related]  

  • 9.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 10.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 11.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 12.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 1.